XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study
2005

Genetic Factors and Smoking in Breast Cancer Risk

Sample size: 965 publication 10 minutes Evidence: moderate

Author Information

Author(s): Metsola Katja, Kataja Vesa, Sillanpää Pia, Siivola Päivi, Heikinheimo Liisa, Eskelinen Matti, Kosma Veli-Matti, Uusitupa Matti, Hirvonen Ari

Primary Institution: Finnish Institute of Occupational Health

Hypothesis

Do polymorphisms in DNA repair genes XRCC1 and XPD modify breast cancer risk, particularly among smokers?

Conclusion

The study suggests that XRCC1 and XPD polymorphisms may increase breast cancer risk among smoking women.

Supporting Evidence

  • Women with at least one XRCC1-399 Gln allele had a 2.33 times higher risk of breast cancer if they were smokers.
  • Ever smoking women with the XPD-751 Gln/Gln genotype had a 2.52 times higher risk of breast cancer.
  • A significant trend of increasing risk was observed with the number of at-risk genotypes among smokers.

Takeaway

Women who smoke and have certain genetic variations may be more likely to get breast cancer.

Methodology

The study analyzed genetic polymorphisms in 483 breast cancer cases and 482 controls using PCR-RFLP methods and logistic regression.

Potential Biases

Potential selection and recall bias, although data were collected prior to diagnosis.

Limitations

The study may have low statistical power for some subgroup analyses due to small sample sizes.

Participant Demographics

Participants were Finnish Caucasian women, with a mean age of 58.9 years for cases and 53.5 years for controls.

Statistical Information

P-Value

0.025

Confidence Interval

95% CI 1.30–4.19

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/bcr1333

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication